News
U.S. and Michigan state flags will be lowered to half-staff Wednesday to honor longtime lawmaker and judge Virgil C. Smith, who died last month. Gov. Gretchen Whitmer announced the honorary measure ...
Lung conditions, like asthma and chronic obstructive pulmonary disease, are more common in women than men. Stephanie Harris ...
Pharmaceutical giant Merck is buying Verona Pharma, a company that concentrates its efforts on respiratory diseases, in an ...
The move bolsters Merck's lineup as it braces for the 2028 loss of patent exclusivity for blockbuster cancer drug Keytruda.
Verona Pharma brings to Merck the inhaled drug Ohtuvayre, which is FDA approved as a treatment for chronic obstructive ...
Police have charged a Reserve Township woman with delivering the bone-breaking punch that caused her 73-year-old mother’s ...
Merck & Co. is acquiring Verona Pharma PLC in a $10 billion deal that will expand the pharmaceutical giant’s portfolio of ...
6d
Clinical Trials Arena on MSNFirst subject dosed in Upstream Bio’s Phase II trial of verekitug for COPDUpstream Bio has dosed the first subject in the Phase II trial of verekitug in individuals with chronic obstructive pulmonary disease (COPD).
Merck said the deal is valued at $107 per ADS, a 23% premium to Verona’s closing price yesterday.
Background Antimicrobial resistance (AMR) is a growing global health crisis and is particularly relevant to people living ...
The deal gives Merck control of Verona’s Ohtuvayre, a newly approved treatment for chronic obstructive pulmonary disease ...
Digital inhalers may help predict occurrence of acute exacerbations of COPD for patients in an ambulatory setting.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results